期刊文献+

甲基纤维素—海藻酸钠复合膜的制备及其性能研究

Study on the preparation and performance of methyl cellulose-sodium alginate composite membrane
下载PDF
导出
摘要 以甲基纤维素(MC)与海藻酸钠(AG)为原料,在不同质量投料比、不同酸度、含不同浓度交联剂的条件下,制备复合膜。实验表明,用CaCl2作交联剂时,组分中甲基纤维素含量高,酸度低,交联剂含量低的配方制成的膜性能优;当组分中海藻酸钠含量高,有一定酸度,并应加入一定量的交联剂所制的膜性能优。最佳成膜的条件是:(1)MC:AG=1:4,用1%的乙酸溶解组分,并加0.05%的交联剂;(2)MC:AG=4:1,用蒸馏水溶解组分,并加入0.025%的交联剂。释药率最高的组分是MC:AG=1:4,可以达到66.42%。药物包封率最高的组分是MC:AG=4:1的组分,可以达到63.16%。 Generates separately the membranes which formed by methyl cellulose (MC) and the sodium alginate(AG) in different feed weight ratio,different acidity,and different density crosslinking agent condition. The results showed that using the crosslinking agent with CaCl2,when the content of methyl cellulose is high,the acidity is low,and the content of crosslinking agent is low,the membrane's performance is superior; When the content of sodium alginate is high,with certain acidity and certain crosslinking agent,the membrane's performance is superior. The best membrane formation condition is: (1) MC:AG=1: 4,using 1% ethanoic acid to dissolute component,with 0.05% crosslinking agent;(2) MC:AG=4:1,using the distilled water to dissolute component,with 0.025% crosslinking agent. The highest drug release rate may achieve 66.42%,it's composition is MC:AG=1:4. The highest drug envelope rate may achieve 63.16%,it's component is MC:AG =4:1.
作者 林鹏英
机构地区 暨南大学化学系
出处 《长春理工大学学报(自然科学版)》 2010年第1期121-124,共4页 Journal of Changchun University of Science and Technology(Natural Science Edition)
关键词 甲基纤维素 海藻酸钠 复合膜 药物释放率 methyl cellulose sodium alginate composite membrane drug release rate
  • 相关文献

参考文献1

二级参考文献5

  • 1Vandenberg GW, Drolet C, Scott SL, et al. Factors affecting protein release from alginate-chitosan coacervate microcapsules during production and gastric/intestinal simulation [ J ]. J Controlled Release, 2001, 77(3) :297.
  • 2Takka S, Acarturk F. Calcium algillate microparticles for oral administration : Ⅰ: effect of sodium alginate type on drug release and drug entrapment efficiency[ J]. J Microencapsulation, 1999, 16(3) :275.
  • 3Gonzalez-Rodriguez ML, Holgado MA, Sanchez-Lafuente C, et al. Alginate/chitosan particulate systems for sodium diclofenac release[J].Int J Pharm, 2002, 232(1-2) :225.
  • 4Rha C,Rodriguez-Sanchez D. Process for encapsulation and encapsulated active material system [P].US Patent: 4 744 933,1988-10-22.
  • 5Sezer AD, Akbug J. Release characteristics of chitosan treated alginate beads: Ⅱ. Sustained release of a low molecular drug from chitosan treated alginate beads[J]. J Microencapsulation, 1999,16(6) :687.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部